Persistent Low Platelets Significantly Increase Death Risk in ICU Patients

Critically ill patients frequently develop thrombocytopenia (low platelet count), a common complication associated with various underlying conditions like sepsis, multi-organ failure, and disseminated intravascular coagulation. While thrombocytopenia is known to worsen patient outcomes, the distinct prognostic implications of transient (temporary) versus persistent (prolonged) forms of this condition in the intensive care unit (ICU) have not been fully elucidated. This study aimed to differentiate the mortality risk associated with transient versus persistent thrombocytopenia in critically ill patients.

The study revealed a significant association between the type of thrombocytopenia and patient mortality. Patients with persistent thrombocytopenia exhibited a substantially higher hospital mortality rate of 48.5%, compared to 21.3% in the transient thrombocytopenia group and 10.2% in patients without thrombocytopenia (p<0.001 for all comparisons). The median ICU length of stay was also significantly longer for patients with persistent thrombocytopenia (14 days) versus transient (7 days) or no thrombocytopenia (5 days). The most critical finding was that patients with persistent thrombocytopenia faced a 3.1-fold higher risk of hospital mortality (Adjusted Odds Ratio 3.12, 95% CI 2.45-3.98) compared to those with transient thrombocytopenia, even after adjusting for confounding factors like APACHE II score and comorbidities. Furthermore, major bleeding events were observed in 18.7% of persistent thrombocytopenia patients, 7.5% in transient, and 2.1% in non-thrombocytopenic patients (p<0.001).